We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+17.08%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$13.4B
AUM Growth
+$5.98B
(+81%)
Cap. Flow
+$3.16B
Cap. Flow
% of AUM
23.6%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$437M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
Amazon
AMZN
|
+$185M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$51.4M |
| 2 |
Lowe's Companies
LOW
|
+$45.3M |
| 3 |
CVS Health
CVS
|
+$37.3M |
| 4 |
Eli Lilly
LLY
|
+$32.7M |
| 5 |
Southern Company
SO
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 11.73% |
| 4 | Healthcare | 8.95% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENZ
1926
DELISTED
Enzo Biochem, Inc.
ENZ
| $427K | ﹤0.01% |
169,430
+38,968
| +30% | +$84.9K |
|
|
PRSP
1927
DELISTED
Perspecta Inc. Common Stock
PRSP
| $427K | ﹤0.01% |
17,721
-220,738
| -93% | -$4.74M |
|
1928
AngioDynamics
ANGO
$635M
| $426K | ﹤0.01% |
27,812
-15,817
| -36% | -$201K |
|
1929
Macy's
M
$5.65B
| $426K | ﹤0.01% |
37,871
-48,560
| -56% | -$415K |
|
1930
Amneal Pharmaceuticals
AMRX
$6.37B
| $425K | ﹤0.01% |
93,034
-70,723
| -43% | -$313K |
|
|
VNE
1931
DELISTED
Veoneer, Inc.
VNE
| $425K | ﹤0.01% |
+19,933
| New | +$377K |
|
|
EGOV
1932
DELISTED
NIC Inc
EGOV
| $425K | ﹤0.01% |
16,443
-38,866
| -70% | -$903K |
|
1933
Ulta Beauty
ULTA
$23.2B
| $424K | ﹤0.01% |
+1,477
| New | +$374K |
|
1934
Warrior Met Coal
HCC
$4.85B
| $423K | ﹤0.01% |
+19,843
| New | +$349K |
|
|
VAPO
1935
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $423K | ﹤0.01% |
1,968
-2,368
| -55% | -$528K |
|
|
DRNA
1936
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $423K | ﹤0.01% |
19,215
-50,801
| -73% | -$1.12M |
|
1937
Genco Shipping & Trading
GNK
$1.22B
| $421K | ﹤0.01% |
57,268
+36,509
| +176% | +$266K |
|
|
AIOT
1938
PowerFleet Inc
AIOT
$399M
| $421K | ﹤0.01% |
56,659
-46,957
| -45% | -$314K |
|
1939
American Vanguard Corp
AVD
$64.3M
| $420K | ﹤0.01% |
27,047
-10,056
| -27% | -$148K |
|
1940
Vanguard Dividend Appreciation ETF
VIG
$110B
| $420K | ﹤0.01% |
+2,975
| New | +$403K |
|
1941
Virtus Investment Partners
VRTS
$851M
| $420K | ﹤0.01% |
1,935
-5,351
| -73% | -$972K |
|
1942
Vodafone
VOD
$40.5B
| $419K | ﹤0.01% |
25,403
+5,883
| +30% | +$92.1K |
|
1943
AMN Healthcare
AMN
$1.34B
| $418K | ﹤0.01% |
6,119
-4,549
| -43% | -$297K |
|
|
PGRE
1944
DELISTED
Paramount Group
PGRE
| $417K | ﹤0.01% |
+46,175
| New | +$372K |
|
|
CFB
1945
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $417K | ﹤0.01% |
38,824
+8,600
| +28% | +$82.6K |
|
1946
Lakeland Industries
LAKE
$104M
| $416K | ﹤0.01% |
+15,276
| New | +$345K |
|
|
TECX
1947
Tectonic Therapeutic
TECX
$532M
| $416K | ﹤0.01% |
2,485
-1,451
| -37% | -$258K |
|
1948
Oppenheimer Holdings
OPY
$1.22B
| $415K | ﹤0.01% |
13,189
-13,068
| -50% | -$368K |
|
|
SRC
1949
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $415K | ﹤0.01% |
10,320
-4,445
| -30% | -$160K |
|
1950
Scholar Rock
SRRK
$5.97B
| $414K | ﹤0.01% |
8,522
-7,892
| -48% | -$287K |
|
Similar funds
VM
Squarepoint's Q4 2020 Portfolio in Review
As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Squarepoint deployed $3.16B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.
- Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
- Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
- Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
- Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
- Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
- Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.
Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.